Endoscopic Ultrasound-guided Biliary Intervention in Patients with Surgically Altered Anatomy
Overview
Affiliations
Aim: To evaluate the efficacy of endoscopic ultrasound guided biliary drainage (EUS-BD) in patients with surgically altered anatomies.
Methods: We performed a search of the MEDLINE database for studies published between 2001 to July 2014 reporting on EUS-BD in patients with surgically altered anatomy using the terms "EUS drainage" and "altered anatomy". All relevant articles were accessed in full text. A manual search of the reference lists of relevant retrieved articles was also performed. Only full-text English papers were included. Data regarding age, gender, diagnosis, method of EUS-BD and intervention, type of altered anatomy, technical success, clinical success, and complications were extracted and collected. Anatomic alterations were categorized as: group 1, Billroth I; group 2, Billroth II; group 4, Roux-en-Y with gastric bypass; and group 3, all other types.
Results: Twenty three articles identified in the literature search, three reports were from the same group with different numbers of cases. In total, 101 cases of EUS-BD in patients with altered anatomy were identified. Twenty-seven cases had no information and were excluded. Seventy four cases were included for analysis. Data of EUS-BD in patients categorized as group 1, 2 and 4 were limited with 2, 3 and 6 cases with EUS-BD done respectively. Thirty four cases with EUS-BD were reported in group 3. The pooled technical success, clinical success, and complication rates of all reports with available data were 89.18%, 91.07% and 17.5%, respectively. The results are similar to the reported outcomes of EUS-BD in general, however, with limited data of EUS-BD in patients with altered anatomy rendered it difficult to draw a firm conclusion.
Conclusion: EUS-BD may be an option for patients with altered anatomy after a failed endoscopic-retrograde-cholangiography in centers with expertise in EUS-BD procedures in a research setting.
Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how?.
Mocan T, Horhat A, Mois E, Graur F, Tefas C, Craciun R World J Gastrointest Oncol. 2022; 13(12):2050-2063.
PMID: 35070041 PMC: 8713328. DOI: 10.4251/wjgo.v13.i12.2050.
Minaga K, Takenaka M, Ogura T, Tamura T, Kuroda T, Kaku T Therap Adv Gastroenterol. 2020; 13:1756284820930964.
PMID: 32774461 PMC: 7391429. DOI: 10.1177/1756284820930964.
Isayama H, Nakai Y, Itoi T, Yasuda I, Kawakami H, Ryozawa S J Hepatobiliary Pancreat Sci. 2019; 26(7):249-269.
PMID: 31025816 PMC: 7064894. DOI: 10.1002/jhbp.631.
Shah R, Tarnasky P, Kedia P Transl Gastroenterol Hepatol. 2019; 3:90.
PMID: 30603726 PMC: 6286912. DOI: 10.21037/tgh.2018.10.10.
Matsumi A, Kato H, Saragai Y, Mizukawa S, Takada S, Muro S Case Rep Gastrointest Med. 2018; 2018:7201967.
PMID: 29984014 PMC: 6015712. DOI: 10.1155/2018/7201967.